Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the newsstand domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u636552293/domains/jvenomres.co.uk/public_html/wp-includes/functions.php on line 6170
The pharmacokinetics of Hemiscorpius lepturus scorpion venom and Razi antivenom following intramuscular administration in rat – Journal of Venom Research

The pharmacokinetics of Hemiscorpius lepturus scorpion venom and Razi antivenom following intramuscular administration in rat

Research Report

J Venom Res (2012), Vol 3, 1-6

Published online: 24 April 2012

Full Text: (PDF 321kb) | (PubMed Central Record HTML)

Amir Jalali †*, Nazanin Bavarsad-Omidian ‡, Mohammad Babaei §, Hossein Najafzadeh ‡, Saeed Rezaei ¥

† Dept of Pharmacology and Toxicology, School of Pharmacy and Toxicology Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran

‡ Faculty of Veterinary Medicine, Shaheed Chamran University, Ahvaz, Iran

§ Radioisotope Unit, Nuclear Energy Organization, Tehran, Iran

¥ Dept of Pharmaceutics, School of Pharmacy and Nanotechnology Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran


*Correspondence to: Amir Jalali, Email: amjalali@hotmail.com, Tel: +98 611 3738380, Fax: +98 611 3738381


Received: 05 December 2011, Revised: 25 February 2012, Accepted: 02 March 2012


© Copyright The Authors


ABSTRACT

Hemiscorpius lepturus (H. lepturus) is one of the most dangerous scorpions in Iran. Intramuscular administration (IM) of available Razi antivenom to H. lepturus venom is used by many of Iranian clinicians. The purpose of the current study was to investigate the efficiency of IM route for treatment of envenomed patients by H. lepturus. We compared the pharmacokinetics parameters of venom and antivenom via subcutaneous (SC) and IM administration, respectively. The blood samples were taken at various predetermined time intervals, i.e., 10, 40, 60, 180, 210, 360 and 400min following 5μg 131I-labeled venom and 5, 10, 40, 120 and 360min following 0.2ml of 131I-labeled antivenom administration. The radio-iodination was carried out using the chloramin-T method. The results showed that pharmacokinetic parameters of the venom were T elimination half-life = 103.25min; Vd/F (apparent volume of distribution) = 14.9ml/kg; Cl/F (total blood clearance) = 0.04ml/kg/min; mean resident residual time (MRT) = 244.3min, and for the antivenom T 1/2 = 628.59min, Vd = 666.66ml/kg, Cl = 0.13ml/kg/min and MRT = 1292min. A comparison of pharmacokinetic profiles indicated that the intramuscular administration was helpful in the referral less than 2hr to clinical centers but not those exceeding 3hr. Overall, the data showed that immunotherapy against H. lepturus stings was likely to be more effective through intravenous administration.

KEYWORDS: Iranian scorpion, Hemiscorpius lepturus, Razi polyvalent, Intramuscular administration